# Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

> **NCT02462460** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 63 (actual)

## Conditions studied

- Screening Breast MRI in Patients Who Are BRCA Mutation Carriers

## Interventions

- **DEVICE:** MRI
- **BEHAVIORAL:** Optional Screening Questionnaire

## Key facts

- **NCT ID:** NCT02462460
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02462460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02462460, "Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02462460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*